A highly significant interaction between the presence of diabetes or chronic kidney disease and stent type on target lesion failure has been reported.[ 23 , 24 , 25 , 26 , 27 ] In a prespecified subgroup analysis, Gwon et al .[ 13 ] found that the treatment effect of DAPT varied depending on the presence of diabetes mellitus.
← all excerpts
Optimizing the duration of dual antiplatelet therapy after implantation of drug-eluting coronary stents.
1
—
—